CELZ Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2024Q3

FY2024Q4

FY2025Q2

0.00

-100%

0.00

-100%

0.00

-100%

Estimates Revision

The market is revising No Change the revenue expectations for Creative Medical Technology Holdings, Inc. (CELZ) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -32.43%.

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-32.43%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Creative Medical Technology Holdings Inc (CELZ.O) is -1.26, compared to its 5-year average forward P/E of -1.31. For a more detailed relative valuation and DCF analysis to assess Creative Medical Technology Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.31

Current PE

-1.26

Overvalued PE

0.80

Undervalued PE

-3.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

1189.37

Current PS

8605.62

Overvalued PS

4036.61

Undervalued PS

-1657.88

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CELZ News & Events

Events Timeline

No data

News

3.5

01-06Globenewswire

Creative Medical Receives Approval to Advance Veterans' Burn Pit Initiative

9.0

2025-12-18NASDAQ.COM

Creative Medical Completes Enrollment for ADAPT Trial on Chronic Lower Back Pain

2.0

2025-12-17Newsfilter

Creative Medical Completes Patient Enrollment in CELZ-201 Clinical Trial

People Also Watch

Frequently Asked Questions

What is Creative Medical Technology Holdings Inc (CELZ) stock price today?

The current price of CELZ is 2.25 USD — it has decreased -8.16 % in the last trading day.

What is Creative Medical Technology Holdings Inc (CELZ)'s business?

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

What is the price predicton of CELZ Stock?

Wall Street analysts forecast CELZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELZ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Creative Medical Technology Holdings Inc (CELZ)'s revenue for the last quarter?

Creative Medical Technology Holdings Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is Creative Medical Technology Holdings Inc (CELZ)'s earnings per share (EPS) for the last quarter?

Creative Medical Technology Holdings Inc. EPS for the last quarter amounts to -0.48 USD, decreased -36.00 % YoY.

What changes have occurred in the market's expectations for Creative Medical Technology Holdings Inc (CELZ)'s fundamentals?

How many employees does Creative Medical Technology Holdings Inc (CELZ). have?

Creative Medical Technology Holdings Inc (CELZ) has 4 emplpoyees as of January 10 2026.

What is Creative Medical Technology Holdings Inc (CELZ) market cap?

Today CELZ has the market capitalization of 7.86M USD.